Publicacións (622) Publicacións nas que participase algún/ha investigador/a

2022

  1. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC

    Revista espanola de cardiologia (English ed.), Vol. 75, Núm. 6, pp. 523

  2. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC

    European journal of heart failure, Vol. 24, Núm. 1, pp. 4-131

  3. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) with the special contribution of the Heart Failure Association (HFA) of the ESC

    Cor et Vasa, Vol. 64, pp. 4-55

  4. 3D printed bioresorbable scaffolds for articular cartilage tissue engineering: A comparative study between neat polycaprolactone (PCL) and poly(lactide-b-ethylene glycol) (PLA-PEG) block copolymer

    Biomedical Materials (Bristol), Vol. 17, Núm. 4

  5. 48-Week effectiveness and tolerability of dolutegravir (DTG) + lamivudine (3TC) in antiretroviral-naïve adults living with HIV: A multicenter real-life cohort

    PLoS ONE, Vol. 17, Núm. 11 November

  6. A Broad-Host-Range Plasmid Outbreak: Dynamics of IncL/M Plasmids Transferring Carbapenemase Genes

    Antibiotics, Vol. 11, Núm. 11

  7. A New Live Auxotrophic Vaccine Induces Cross-Protection against Klebsiella pneumoniae Infections in Mice

    Vaccines, Vol. 10, Núm. 6

  8. A comprehensive characterization of acute heart failure with preserved versus mildly reduced versus reduced ejection fraction – insights from the ESC-HFA EORP Heart Failure Long-Term Registry

    European Journal of Heart Failure, Vol. 24, Núm. 2, pp. 335-350

  9. A nop56 Zebrafish Loss-of-Function Model Exhibits a Severe Neurodegenerative Phenotype

    Biomedicines, Vol. 10, Núm. 8

  10. A novel Troponin I mutation associated with severe restrictive cardiomyopathy - A case report of a 27-year-old woman with fatigue

    European Heart Journal - Case Reports, Vol. 6, Núm. 2

  11. A pleural ultrasound image of a collapsed lung surrounded by pleural fluid (“jellyfish sign”) may correspond to an intrapericardial mass

    Journal of Ultrasound, Vol. 25, Núm. 2, pp. 387-390

  12. A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function

    Kidney International, Vol. 101, Núm. 1, pp. 174-184

  13. A predictive model of lymph node metastasis for thymic epithelial tumours

    European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, Vol. 62, Núm. 5

  14. A propósito de dos casos de trombosis ovárica

    Galicia Clínica, Vol. 83, Núm. 2, pp. 72-73

  15. A randomised phase 2 study comparing different dose approaches of induction treatment of regorafenib in previously treated metastatic colorectal cancer patients (REARRANGE trial)

    European Journal of Cancer, Vol. 177, pp. 154-163

  16. A randomised phase II study of osimertinib and bevacizumab versus osimertinib alone as second-line targeted treatment in advanced NSCLC with confirmed EGFR and acquired T790M mutations: the European Thoracic Oncology Platform (ETOP 10-16) BOOSTER trial

    Annals of Oncology, Vol. 33, Núm. 2, pp. 181-192

  17. A randomized phase II study comparing consolidation with a single dose of 90Y ibritumomab tiuxetan vs. maintenance with rituximab for two years in patients with newly diagnosed follicular lymphoma responding to R-CHOP. Long-term follow-up results

    Leukemia and Lymphoma, Vol. 63, Núm. 1, pp. 93-100

  18. A red flag before patent foramen ovale closure: recognizing the incomplete cor triatriatum dexter

    International Journal of Cardiovascular Imaging, Vol. 38, Núm. 1, pp. 113-115

  19. A resilient type of familial hypercholesterolaemia: case-control follow-up of genetically characterized older patients in the SAFEHEART cohort

    European Journal of Preventive Cardiology, Vol. 29, Núm. 5, pp. 795-801

  20. Abdominal normothermic regional perfusion in controlled donation after circulatory determination of death liver transplantation: Outcomes and risk factors for graft loss

    American Journal of Transplantation, Vol. 22, Núm. 4, pp. 1169-1181